Home > Insider Trading > Filing (0001562180-24-008101)

Filing Details

Accession Number:: 0001562180-24-008101
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-03 16:16:02
Reporting Period:: 2024-12-01

Accepted Time:: 2024-12-03 16:16:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1568651	Oscar Health Inc.	OSCR	Hospital & Medical Service Plans (6324)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1667819	C. Alessandrea Quane	75 Varick Street, 5Th Floor New York NY 10013	Evp, Chief Insurance Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-12-01	7,015	$0.00	399,622	No	4	M	Direct
Class A Common Stock	Acquisiton	2024-12-01	34,379	$0.00	434,001	No	4	M	Direct
Class A Common Stock	Acquisiton	2024-12-01	8,653	$0.00	442,654	No	4	M	Direct
Class A Common Stock	Disposition	2024-12-02	26,411	$18.07	416,243	No	4	S	Direct
Class A Common Stock	Disposition	2024-12-02	484	$18.48	415,759	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Units	Disposition	2024-12-01	7,015	$0.00	7,015	$0.00
Class A Common Stock	Restricted Stock Units	Disposition	2024-12-01	34,379	$0.00	34,379	$0.00
Class A Common Stock	Restricted Stock Units	Disposition	2024-12-01	8,653	$0.00	8,653	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,048	No	4	M	Direct
309,417	No	4	M	Direct
77,872	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	76,857	Indirect	Alessandrea C Quane 2024 GRAT

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.